Pharmaceutical giant Johnson and Johnson, which saw distribution of its COVID-19 vaccine temporarily halted due to isolated health concerns, is on track to “have the pause remedied,” a top executive said.
Brazil’s battle against a dangerous coronavirus variant has left its hospitals at breaking point, with new cases skyrocketing and the death toll climbing precipitously.
While the FDA and CDC have put a pause on the Johnson & Johnson vaccine, for now, the medical community still recommends people get either the Pfizer and Moderna vaccine to protect against the coronavirus in the meantime.
Variants of the coronavirus are increasingly defining the next phase of the pandemic in the United States, taking hold in ever-greater numbers and eliciting pleas for a change in strategy against the outbreak, according to government officials and experts tracking developments.
Views of the CDC changed during the coronavirus pandemic and are now strongly politicized, according to researchers
Moderna’s COVID-19 vaccine also seemed to protect against the U.K. variant
It’s possible, say experts, but the risk is low
Mutations of the coronavirus could render current vaccines ineffective within a year, according to a survey of experts in 28 countries.
New Covid-19 cases have spiked in the US in the last several days, the latest data showed Tuesday — and White House and health officials are pleading with the country to take more precautions until more people can be vaccinated.
After six straight weeks of declines in new Covid-19 cases in the US, that number has started to plateau, even as hospitalizations and deaths continue to drop.